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Peroxynitrite has been suggested to be the potent oxidant causing toxicity to neurons and oligodendrocytes
(OLs). Our previous studies have illustrated that intracellular zinc liberation contributes to peroxynitrite
toxicity tomature OLs. In this study, we further investigated the signaling pathways involved in this event and
identified protein kinase C (PKC) as an important early signaling molecule. We found that a non-selective PKC
inhibitor bisindolylmaleimide-1 blocked OL toxicity induced by a peroxynitrite generator SIN-1 and
exogenous zinc. The protective effects were due to its inhibition on ERK1/2 phosphorylation and ROS
generation. The same phenomenon was also observed in OLs following prolonged treatment with phorbol 12
myristate 13 acetate (PMA), which downregulates the conventional and the novel PKC isoforms (cPKCs and
nPKCs). To determine the role of specific PKC isoforms, we found that a specific nPKC inhibitor rottlerin
significantly reduced SIN-1- or zinc-induced toxicity, whereas Go6976, a cPKC inhibitor, reduced OL toxicity
triggered by zinc, but not by SIN-1 at high concentrations. Rottlerin was more potent than Go6976 to
attenuate ERK1/2 phosphorylation and ROS generation induced by SIN-1 or zinc. Surprisingly, zinc only
induced phosphorylation of PKCθ, but not PKCδ. Knockdown of PKCθ using lentiviral shRNA attenuated SIN-1-
or zinc-induced toxicity. These results suggest that PKCθ might be the major PKC isoform involved in
peroxynitrite and zinc toxicity to mature OLs, and provide a rationale for development of specific inhibitors of
PKCθ in the treatment of multiple sclerosis and other neurodegenerative diseases, in which peroxynitrite
formation plays a pathogenic role.
Published by Elsevier Inc.
Introduction
Oligodendrocytes (OLs) are myelin forming cells in the central
nervous system (CNS). They produce myelin sheath to wrap axons
and enable the saltatory propagation of action potentials. Destruction
of myelin sheath, impediment of remyelination and loss of mature OLs
are common features in many neurological diseases including
cerebral palsy and multiple sclerosis (Pleasure et al., 2006).
Oxidative stress is one of the important causes for multiple
sclerosis (Calabrese et al., 2002). Peroxynitrite, the reaction product of
nitric oxide and superoxide, is the most powerful oxidant so far
identified (Pacher et al., 2007). It has been suggested that peroxyni-
trite is the principal toxic species released from reactive microglia
causing toxicity to neurons and OLs (Li et al., 2005; Xie et al., 2002).
Although it is known that peroxynitrite can cause DNA damage,
protein oxidation and lipid peroxidation (Beckman and Koppenol,
1996; Pacher et al., 2007), the cell death mechanisms triggered by
peroxynitrite have not been well elucidated. We have previously
shown that peroxynitrite toxicity to mature OLs is mediated by
intracellular zinc release, activation of extracellular signal-regulated
kinase 1/2 (ERK1/2), 12-lipoxygenase (12-LOX) and the formation of
reactive oxygen species (ROS) (Zhang et al., 2006). Since protein
kinase C (PKC) is particularly sensitive to redox stress, and is involved
in zinc-induced ROS generation (Koh, 2001; Noh et al., 1999), we
hypothesize that activation of PKC might be critically involved in the
signaling pathways of peroxynitrite toxicity to OLs.
PKC is a family of serine and threonine kinases, which sense the
environmental cues and trigger the signaling pathways critical for cell
proliferation,migration, differentiation and survival (Giorgi et al., 2010).
There are at least 10 PKC isoforms, which are classified into three
categories according to the cofactors that are required for the catalytic
activity: 1) the conventional or classical PKCs (cPKC:α, βI,βII andγ) are
calcium dependent and stimulated by diacylglycerol (DAG); 2) the
novel PKCs (nPKC: δ, ε, η and θ) are activated by DAG, but are calcium
independent; and 3) the atypical PKCs (aPKC: λ, ι and ζ) are insensitive
to both calcium and DAG (Newton, 2003). The different isoforms of PKC
have been shown to be developmentally regulated and suggested to be
involved in the myelin gene expression in OLs (Asotra and Macklin,
1993, 1994; Bhat et al., 1995). However, it is unknown whether
activation of the different PKC isoforms can also lead to OL toxicity.
Using primary cultures of mature OLs, we found that the toxicity of
OLs induced by SIN-1, a commonly used donor of peroxynitrite, or zinc,
is mediated by activation of cPKC and nPKC isoforms. Pharmacological
and molecular approaches further indicate that nPKCs, especially PKCθ,
may play a predominant role in triggering OL cell death, which is
mediated by ERK1/2 phosphorylation and ROS generation.
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Results
The pan PKC inhibitor bisindolylmaleimide 1 protected against SIN-1 or
zinc induced toxicity to mature OLs
Activation of PKC has been found to mediate zinc induced ROS
generation and neuronal toxicity (Noh et al., 1999). We have
previously shown that peroxynitrite toxicity to mature OLs is
mediated by intracellular zinc release and the subsequent ERK1/2
phosphorylation and ROS generation (Zhang et al., 2006). Therefore, it
is likely that PKC activation also participates in peroxynitrite toxicity
to mature OLs. Treatment of mature OLs with SIN-1 (0.5 mM), a
peroxynitrite generator, or ZnCl2 (100 μM) for 30 min caused a
significant increase in PKC activity, and the increase was completely
blocked by the pan PKC inhibitor, bisindolylmaleimide-1 (Bis-1,
10 μM) (Fig. 2A). Bis-1 dose-dependently attenuated SIN-1 or zinc
induced toxicity to mature OLs. The EC50 for Bis-1 in reducing SIN-1
or zinc toxicity is about 2 μM. Bis-1 at 10 μM completely blocked OL
toxicity induced by SIN-1 and ZnCl2 (Figs. 2B and C).
Bis-1 attenuated SIN-1 or ZnCl2 induced ERK1/2 phosphorylation and
ROS generation
To determinewhether the protective effect of the pan PKC inhibitor is
due to its inhibition of ERK1/2 phosphorylation, OLs were treated with
SIN-1 or ZnCl2 for 60 and 120 min, and the effect of Bis-1 on ERK1/2
phosphorylation was assessed by western blot analysis. SIN-1 (0.5 mM)
induced a significant ERK1/2 phosphorylation at 2 h, which was almost
completely blocked by Bis-1 at 10 μM (Fig. 3A). Similarly, ZnCl2 (100 μM)
induced ERK1/2 phosphorylation was also attenuated by Bis-1 (Fig. 3B).
OLs + AS 
OLs + MG 
A 
B 
Fig. 1. The purity of cultures of mature OLs. A, Following 2 weeks incubation in BDM
plus T3 and CNTF culture medium, cells were fixed with 4% paraformaldehyde and
immunostained with antibodies against MBP and GFAP, markers for mature OLs and
astrocytes, respectively. Few GFAP positive astrocytes (AS; green labeled cells shown
with arrows) were present in cultures of mature OLs (red). Nuclei were stained with
DAPI (blue). B, Isolectin, a selective marker for microglia (MG; green staining cells
shown with arrows), was used to detect the contamination of MG in cultures of mature
OLs (red). Nuclei were stained with DAPI (blue).
Fig. 2. The pan PKC inhibitor Bis-1 blocked PKC activation and mature OL toxicity
induced by SIN-1 and ZnCl2. A, Mature OLs were exposed to a peroxynitrite donor SIN-1
(0.5 mM) or ZnCl2 (100 μM) in the absence or presence of Bis-1 for 30 min, and then
lysed for assaying the PKC activity. **, pb0.01 and ***, pb0.001 were obtained when the
SIN-1 and the zinc treated groups were compared with the control group. ##, pb0.01
was obtainedwhen the Bis-1 treated groupswere comparedwith SIN-1 alone and ZnCl2
alone groups. A representative experiment of three that were performed is shown. B,
OLs were exposed to SIN-1 (0.5 mM) in the absence or presence of Bis-1 for 2 h, and the
toxicity was assessed at 24 h. Bis-1 dose-dependently protected against SIN-1 induced
toxicity. *, pb0.05 and **, pb0.01 were obtained when the Bis-1 treated SIN-1 groups
were compared with the SIN-1 alone group. A representative experiment of six that
were performed is shown. C, OLs were exposed to ZnCl2 (100 μM) in the absence or
presence of Bis-1 for 2 h, and the toxicity was assessed at 24 h. Bis-1 dose-dependently
protected against ZnCl2 induced toxicity. *, pb0.05 and ***, pb0.001 were obtained
when the Bis-1 treated ZnCl2 groups were compared with the zinc alone group. A
representative experiment of six that were performed is shown.
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Quantitationof thewesternblotsbydensitometry showed that the ratioof
the phosphorylated versus the total ERK1/2 at 2 h following ZnCl2
treatment was increased up to 6-fold, when compared to the early time
points. In the presence of Bis-1, it was reduced to 40±15% of the levels in
zinc alone treated group (n=3, pb0.01).We next examined the effect of
Bis-1 on SIN-1 or zinc induced ROS generation by quantitative analysis of
DCF fluorescence. SIN-1 (0.5 mM) caused a 15-fold increase of ROS
generation, as indicated by the enhanced DCF fluorescence intensity, and
the ROS generation was dose-dependently reduced by Bis-1 treatment
(Fig. 3C). Similarly, ZnCl2 (100 μM) also dose-dependently induced ROS
generation, which was almost completely blocked by Bis-1 at each of the
three concentrations (1, 3 and 10 μM) (Fig. 3D).
Expression of various PKC isoforms in mature OLs and their
downregulation by prolonged PMA treatment
To determine which PKC isoforms are expressed in mature OLs, we
used PKC isoform specific primers and isoform selective antibodies to
assess the mRNA and the protein levels of the various PKC isoforms.
Reverse transcriptase PCR revealed that all the PKC isoforms,
including the cPKCs (α, β and γ), the nPKCs (η, ε, δ and θ), and the
aPKCs (ι/λ and ζ), are expressed in mature OLs, with a particularly
high expression of PKCβ (Fig. 4A). Similar to the findings by Asotra
and Macklin (1994), we found that the conventional PKCα and PKCβ
are highly expressed in mature OLs, whereas no expression of PKCγ
was detected by western blot (Fig. 4B). Among the novel PKC
isoforms, PKCθ and PKCε were highly expressed, the expression of
PKCδ was intermediate and the PKCη expression was undetectable
(Fig. 4B). The expression of the atypical PKCι, PKCλ and PKCζwas also
found in mature OLs (Fig. 4B). It is known that prolonged treatment
with PMA can cause downregulation of several PKC isoforms by
ubiquitination and proteasomal degradation (Leithe et al., 2003).
After 24 h pretreatment with PMA, both the cPKCs (α and β) and the
nPKCs (θ, ε and δ) were downregulated, whereas the expression of
aPKCs (ι/λ and ζ) was not affected (Fig. 4B). This result is consistent
with the fact that PMA binds to the conventional and the novel PKCs,
but not to the atypical PKCs (Steinberg, 2008).
Prolonged treatment of OLs with PMA attenuated SIN-1 or zinc induced
toxicity, ERK1/2 phosphorylation and ROS generation
At 24 h after PMA pretreatment, OLs were found to be completely
resistant to SIN-1 (0.5 mM) or zinc (100 μM) induced toxicity
(Fig. 5A), suggesting that activation of cPKC and nPKC, but not aPKC,
is involved in the toxicity of OLs. Consistent with the results obtained
by using Bis-1 (Fig. 3), SIN-1 and zinc induced ERK1/2 phosphoryla-
tionwas also dramatically reduced by PMA pretreatment (Figs. 5B and
C). OLs pretreatedwith PMA for 24 h partially reduced ROS generation
induced by SIN-1 (Fig. 5D), whereas the ROS generation induced by
zinc was almost completely blocked (Fig. 5E). These results suggest
that both zinc dependent and independent mechanisms are involved
in SIN-1 induced ROS generation in mature OLs.
Effects of selective inhibition of the different PKC isoforms on OL toxicity
induced by SIN-1 and zinc
Considering the fact that Bis-1, as well as the prolonged treatment
with PMA, can reduce the activity of both cPKCs and nPKCs, it is
unclear how cPKCs and nPKCs can differentially contribute to SIN-1 or
zinc induced toxicity to OLs. Go6976 and rottlerin are the commonly
A 
B 
C 
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SIN-1 Bis /SIN-1
0 60’ 120’0 60’ 120’
p-ERK1/2 
ERK1/2 
Actin 
p-ERK1/2 
ZnCl2  Bis /ZnCl2 
0      60’   120’ 0      60’   120’ 
ERK1/2 
Actin 
Fig. 3. Bis-1 attenuated SIN-1 and ZnCl2 induced ERK1/2 phosphorylation and ROS generation in OLs. A–B, OLs were treated with SIN-1 (0.5 mM) or ZnCl2 (100 μM) in the absence or
presence of Bis-1 for 60 min and 120 min, and then lysed for western blot analysis. The phosphorylation of ERK1/2 induced by SIN-1 (A) or ZnCl2 (B) was attenuated by Bis-1 at
10 μM. The expression of ERK1/2 was unaltered in all the treatment conditions, and β-actin was used as a loading control. A representative experiment of three that were performed
is shown. C–D, OLs were treated with SIN-1 (0.5 mM) or ZnCl2 (100 μM) in the absence or presence of Bis-1 for 2 h, and then exposed to DCF for 30 min. ROS generation induced by
SIN-1 (C) or ZnCl2 (D), as indicated by the fold increase of DCF fluorescence intensity (F.I.) was significantly attenuated by Bis-1 at various concentrations. ***, pb0.001 was obtained
when the Bis-1 treated SIN-1(C) and ZnCl2 groups (D) were compared to the untreated SIN-1 (C) and ZnCl2 groups (D), respectively. A representative experiment of six that were
performed is shown.
64 S. Li et al. / Molecular and Cellular Neuroscience 48 (2011) 62–71
used cPKC and nPKC inhibitors, respectively (Goekjian and Jirousek,
1999; Gschwendt et al., 1994). Go6976 at 3 μM significantly
attenuated OL toxicity induced by SIN-1 at 0.5 mM, but not at 1 mM
(Fig. 6A). Rottlerin at 3 μM attenuated OL toxicity induced by SIN-1 at
both concentrations (Fig. 6A). Go6976 and rottlerin significantly
attenuated zinc toxicity to mature OLs (Fig. 6B). These results suggest
that both the conventional and the novel PKC isoforms contribute to
the toxicity of OLs induced by exogenous zinc. However, the
involvement of PKCs in SIN-1 induced toxicity to OLs appears to be
dependent on the concentrations of SIN-1 used. At relatively low
concentration, SIN-1 toxicity is mediated by both cPKC and nPKC
isoforms, whereas at high concentration, the toxicity of SIN-1 seems
to be mediated by activation of the novel PKCs only.
Effects of Go6976 and rottlerin on SIN-1 and zinc induced ERK1/2
phosphorylation and ROS generation
Because both Go6976 and rottlerin were shown to protect against
SIN-1/ZnCl2 induced toxicity to mature OLs, we speculated that these
inhibitors would attenuate ERK1/2 phosphorylation and ROS genera-
tion. Similar to the effect of Bis-1 on the phosphorylation of ERK1/2
induced by SIN-1 and zinc (Figs. 3A and B), rottlerin (3 μM) and Go6976
(3 μM) also reduced ERK1/2 phosphorylation in OLs induced by SIN-1
and ZnCl2 (Fig. 7A). Notably, a better inhibition was provided by
rottlerin than Go6976. Rottlerin also showed a greater inhibitory
effect than Go6976 on SIN-1/zinc induced ROS generation (Figs. 7B–E).
Go6976 at 1 and 3 μM significantly attenuated ROS generation
induced by SIN-1 at 0.5 mM, but not at 1 mM (Fig. 7B). Rottlerin at
1 and 3 μM reduced ROS generation induced by SIN-1 at both
concentrations (Fig. 7C). Similarly, Go6976 from 0.1 to 3 μM reduced
ROS generation by 50%, whereas rottlerin dose-dependently atten-
uated ROS generation and a complete inhibition was obtained by
rottlerin at 3 μM (Figs. 7D and E). These results suggest that nPKCs
might be the major PKC isoforms involved in SIN-1 and zinc toxicity
to OLs.
Downregulation of PKCθ reduced OL toxicity induced by zinc and SIN-1
Although rottlerin is commonly used as a selective inhibitor for
PKCδ (Gschwendt et al., 1994), the high sequence homology between
PKCδ and PKCθ suggests that PKCθ may be also inhibited by rottlerin
(Baier and Wagner, 2009; Boschelli, 2009). It has been documented
that PKC activity is under control of its phosphorylation (Newton,
2010; Parekh et al., 2000), therefore, we examined whether zinc can
affect the phosphorylation of PKCθ and PKCδ in mature OLs. At 2 h
after zinc treatment, there is a 3-fold increase of PKCθ phosphoryla-
tion in mature OLs. The phosphorylation was completely blocked by
rottlerin (3 μM), but not affected by Go6976 (3 μM) (Fig. 8A). Bis-1
(10 μM) slightly attenuated ERK1/2 phosphorylation. Surprisingly, we
found that the phosphorylation of PKCδ was not increased at 2 h
following zinc treatment (Fig. 8A). Therewas no difference in the ratio
of the phosphorylated and the total PKCδ in all the treatment
conditions (n=3). This result suggests that PKCθ, but not PKCδ, is
activated by zinc treatment. To further test the role of PKCθ in the
signaling pathways of OL cell death, we used RNA interference to
specifically downregulate the expression of PKCθ in mature OLs.
Infection of OLs with shPKCθ lentiviral particles for 4 days caused a
dramatic downregulation of PKCθ, when compared to the non-
infected and the GFP shRNA lentiviral particle infected controls
(Fig. 8B). Downregulation of PKCθ significantly reduced zinc and SIN-
1 induced toxicity to mature OLs (Figs. 8C and D). Although PKCε is
also expressed in mature OLs, the involvement of PKCε in the cell
death pathways of OLs is likely to be excluded, because the IC50 of
rottlerin for PKCε is up to 80–100 μM (Gschwendt et al., 1994). Taken
together, these results suggest that PKCθ might be the major nPKC
isoform involved in the OL toxicity induced by SIN-1/zinc.
Discussion
It is well documented that PKCs are particularly sensitive to redox
modification and the altered PKC activity can regulate diverse cellular
functions, including proliferation, differentiation, survival and death
(Giorgi et al., 2010). Although numerous studies have suggested that
various PKC isoforms are involved in neuronal survival and death
(Aras et al., 2009; Miller et al., 2009; Nelson and Alkon, 2009), the role
of PKCs in oxidative stress induced toxicity to OLs has not been
elucidated. In this study, we found that PKCs are important signaling
proteins involved in the cell death pathways triggered by the potent
oxidant, peroxynitrite. Consistent with our previous findings that
peroxynitrite toxicity to mature OLs is partially mediated by
intracellular zinc liberation (Zhang et al., 2006), the cell death
induced by both SIN-1, a donor of peroxynitrite, and zinc is triggered
by activation of cPKC and nPKC isoforms. However, the involvement of
different PKC isoforms in SIN-1 induced toxicity to OLs is dependent
on the concentrations of SIN-1 used. At high concentration, the
toxicity of SIN-1 seems to be mediated by the novel PKCs, but not by
the conventional PKCs. PKCθ is likely the major PKC isoform
contributing to peroxynitrite-/zinc-induced toxicity to OLs.
PKCλ
PKCζ
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Fig. 4. Expression of various PKC isoforms in mature OLs. A, RNA samples isolated from
OLs were analyzed by reverse transcriptase PCR using the primer pairs (see Table 1)
specific for rat PKC α, β, γ, η, ε, δ, θ, λ and ζ. The products were run on a 1% agarose gel
impregnated with ethidium bromide. The bands were visualized under UV light. A
representative experiment of three that were performed is shown. B, Mature OLs were
treated with PMA (100 nM) for 24 h and then lysed to detect the expression of various
PKC isoforms. The isoform specific antibodies were used to compare the expression of
each PKC specific isoform with and without PMA prolonged treatment. β-actin was
used as a loading control for lysates from control (CON) and PMA pretreated cells. A
representative experiment of three that were performed is shown.
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The PKC family proteins are composed of an N-terminal regulatory
domain and a C-terminal catalytic domain linked by a flexible hinge
region (Stabel and Parker, 1991). The C-terminal catalytic domain is
highly conserved among all the PKC isoforms, whereas the N-terminal
regulatory domain determines the specificity of the various PKC
isoforms. The C1 and C2 domains in the N-terminal region of the
classical PKCs bind to DAG and calcium, respectively. The novel PKCs
lack the C2 homologous domain, and the C2 and part of the C1
domains are absent in the atypical PKCs. Because of these structural
differences, the novel PKCs are known to be calcium independent, and
the atypical PKCs are insensitive to both DAG and calcium (Giorgi et
al., 2010). Using the PKC isoform specific antibodies, we found that the
classical PKCα and PKCβ, the novel PKCθ, PKCδ and PKCε, and the
atypical PKCι/λ and PKCζ are expressed in mature OLs. Prolonged
treatment with PMA, a commonly used analog of DAG, downregulates
PKCα, β, θ, δ and ε, but not PKCι/λ and ζ. Because the pan PKC
inhibitor and the prolonged PMA treatment completely prevent
mature OLs from SIN-1 or zinc induced toxicity, we speculated that
activation of the classical PKCs (PKCα and PKCβ) and the novel PKCs
(PKCθ, PKCδ and PKCε) contributes to the toxicity of OLs induced by
peroxynitrite or zinc.
It is known that both the N-terminal and the C-terminal regions of
PKCs can be redox regulated (Gopalakrishna and Jaken, 2000).
Oxidation of the cysteine-rich zinc finger motifs in the N-terminal
domain can liberate free zinc and activate the kinases. However, at
high concentration, oxidative agents can directly react with the C-
terminal catalytic region and cause inactivation of the kinase (Giorgi
et al., 2010). Our results showed that the inhibitors of both cPKCs and
A 
B 
D 
E SIN-1
0 60’ 90’ 0 60’ 90’
PMA/SIN-1  
p-ERK1/2 
ERK1/2 
Actin 
ZnCl2
0 60’ 120’ 0 60’ 120’
PMA/ZnCl2
p-ERK1/2 
ERK1/2 
Actin 
C 
Fig. 5. Prolonged treatment with PMA attenuated OL toxicity, ERK1/2 phosphorylation and ROS generation induced by SIN-1 and zinc. A, Following 24 h pretreatment with PMA (100
nM), OLs were exposed to SIN-1 and ZnCl2 for 2 h, and the toxicity was assessed at 20–24 h. Prolonged treatment with PMA significantly blocked SIN-1 or ZnCl2 induced toxicity to
OLs (***, pb0.001). B, Following 24 h pretreatment with PMA, OLs were exposed to SIN-1 (0.5 mM) for 60 min and 90 min, and then lysed for western blot analysis. PMA prolonged
treatment attenuated SIN-1 induced phosphorylation of ERK1/2. A representative experiment of three that were performed is shown. C, Following 24 h pretreatment with PMA, OLs
were exposed to ZnCl2 (200 μM) for 60 min and 120 min, and then lysed for western blot analysis. PMA prolonged treatment attenuated ZnCl2 induced phosphorylation of ERK1/2. A
representative experiment of three that were performed is shown. D–E, OLs were pretreated with PMA for 24 h, and then exposed to SIN-1 or ZnCl2 for 2 h. After washing with EBSS,
cells were exposed to DCF for 30 min. ROS generation induced by SIN-1 (D) or ZnCl2 (E) was significantly attenuated by prolonged PMA treatment (*, pb0.05 and ***, pb0.001). A
representative experiment of six that were performed is shown.
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nPKCs attenuated OL toxicity induced by SIN-1 at 0.5 mM, but only the
inhibitor of nPKCs, but not the inhibitor of cPKCs, reduced SIN-1
induced toxicity at higher concentrations. SIN-1 or peroxynitrite
induced PKC activation may occur simultaneously with zinc liberation
from PKC, or is caused by zinc released from mitochondria and the
other zinc binding proteins, such as metallothioneins and zinc finger
proteins (Hao and Maret, 2005; Maret, 2008; Zhang et al., 2007).
Recently, an elegant study has demonstrated that mutations in a zinc
finger protein ZFP191 can disrupt the myelinating function of
differentiated OLs (Howng et al., 2010). We speculate that the release
of zinc from ZFP191 may inhibit its function and reduce the
expression of an array of myelin-related genes. To support the
hypothesis that zinc can directly activate PKC in OLs, we found
exogenous zinc can also cause PKC activation, and the toxicity of zinc
is blocked by the PKC inhibitors. Inhibition or degradation of PKCs by
PMA attenuates SIN-1 or zinc induced ERK1/2 phosphorylation and
ROS generation, suggesting PKCs are the early signaling molecules in
the cell death pathways. It is unclear how PKCs are activated by zinc.
The fact that exogenous zinc induced toxicity can be blocked by both
the classical and the novel PKC inhibitors, suggesting that zinc entry
may also affect the homeostasis of the intracellular calcium and the
membrane phospholipids, although the generation of ROSmay in turn
activate PKCs and form a positive feedback loop, which may occur in
the absence of the cofactors (Giorgi et al., 2010).
It is interesting to note that the OL toxicity induced by SIN-1 at
high concentrations seems to be mediated by activation of the novel
PKC isoforms, but not the classical PKCs. Among the novel PKC
isoforms, we found that PKCθ, PKCδ and PKCε are depleted by the
prolonged PMA treatment and the expression of PKCη is undetectable
in mature OLs. These results suggest that the novel PKC isoforms
involved in SIN-1 or peroxynitrite toxicity to mature OLs might be
either the individual or the combination of PKCθ, PKCδ and PKCε. The
low affinity of rottlerin to PKCε (80–100 μM) (Gschwendt et al., 1994)
suggests that it is unlikely that this novel PKC isoform is involved in
peroxynitrite toxicity to mature OLs. Moreover, activation of PKCε is
generally thought to be protective against oxidative stress induced
injury (Barnett et al., 2007; Shirai et al., 2008). Conversely, PKCδ has
been shown to cause cell death in a variety of oxidative and
pathological conditions (Murriel andMochly-Rosen, 2003). Hydrogen
peroxide (H2O2) and depletion of glutathione (GSH), the endogenous
antioxidant, have been shown to activate PKCδ and induce cell death
in culture (Domenicotti et al., 2003;Majumder et al., 2001). Activation
of PKCδ is also found to trigger apoptotic cell death in the animal
models of ischemia, Parkinson's disease, Alzheimer's disease and
several other neurological diseases (Kanthasamy et al., 2003). It is
demonstrated that activation of PKCδ occurs via its cleavage by
caspase-3 at the hinge region between the regulatory and the catalytic
domains resulting in the generation of a persistently active 41-kDa
catalytic fragment (Kanthasamy et al., 2003). Therefore, PKCδ is likely
not activated and involved in a more aggressive, necrotic cell death. In
this study, we found that zinc does not induce PKCδ phosphorylation,
consistent with our previous findings that the cell death of mature OLs
induced by peroxynitrite and zinc is possibly non-apoptotic (Zhang
and Rosenberg, 2004; Zhang et al., 2006). This result indicates that
PKCδmay not be involved in peroxynitrite and zinc induced toxicity to
mature OLs.
PKCθ is structurally the closest PKC isoform compared to PKCδ, the
catalytic domains of PKCθ and PKCδ are 76% identical (Boschelli,
2009). Although PKCθ is mainly expressed in lymphocytes, skeletal
muscle, and platelets (Hayashi and Altman, 2007), we found that the
levels of the mRNA and the protein expression of PKCθ in mature OLs
are compatible to those of PKCδ and PKCε. Our results showed that
zinc induced a significant phosphorylation of PKCθ, which was almost
completely blocked by rottlerin. Surprisingly, PKCδ is not phosphor-
ylated by zinc, again indicating that it might not be involved in zinc
induced toxicity to mature OLs. Knockdown of PKCθ renders OLs
resistant to zinc and SIN-1 induced toxicity, suggesting activation of
PKCθ is involved in the cell death pathway. It has been reported that
mouse with targeted gene deletion of PKCθ is resistant to the
induction of experimental autoimmune encephalomyelitis (EAE), an
animal model of multiple sclerosis (Salek-Ardakani et al., 2005; Tan et
al., 2006). Although inhibition of lymphocytes proliferation and
infiltration to the CNS in PKCθ knockout mice is attributable to the
inability of EAE induction (Salek-Ardakani et al., 2005; Tan et al.,
2006), lack of PKCθ activation in mature OLs may also contribute
significantly to the protective effects against oxidative stress induced
injury to mature OLs. This result suggests that selective PKCθ
inhibitors can be used as therapeutic agents to prevent OL toxicity
in multiple sclerosis, traumatic brain and spinal cord injury and the
other neurological diseases in which peroxynitrite formation may
play an important role.
Experimental methods
Materials
SIN-1 was obtained from Cayman Chemical Co. (Ann Arbor, MI).
Go6976 and rottlerin were obtained from Tocris Bioscience (Missouri,
USA). 2′,7′-dichlorohydrofluorescein diacetate (DCF) was purchased
from Molecular Probes, Inc. (Eugene, OR). All the culture materials
were purchased from Gibco Life Technologies (Grand Island, NY).
Platelet-derived growth factor (PDGF), basic fibroblast growth factor
(bFGF), and ciliary neurotrophic factor (CNTF) were from Peprotech
(Princeton, NJ). All other reagents were obtained from Sigma (St.
Louis, MO).
Fig. 6. Go6976 and rottlerin attenuated SIN-1 and zinc induced toxicity to OLs. A,
Mature OLs were exposed to SIN-1 in the presence of Go6976 or rottlerin for 2 h, and
the toxicity was assessed at 20–24 h. Go6976 attenuated OL toxicity induced by SIN-1 at
0.5 mM, but not at 1 mM. Rottlerin reduced OL toxicity induced by SIN-1 at both
concentrations. **, pb0.01 and ***, pb0.001 were obtained when the Go6976 or the
rottlerin treated SIN-1 groups were compared with the respective SIN-1 alone groups. A
representative experiment of six that were performed is shown. B, Mature OLs were
exposed to ZnCl2 in the presence of Go6976 or rottlerin for 2 h, and the toxicity was
assessed at 20–24 h. ***, pb0.001 was obtained when the Go6976 or the rottlerin
treated zinc groups were compared with the zinc alone groups. A representative
experiment of six that were performed is shown.
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Oligodendrocyte culture
Primary cultures of OLs were prepared by shaking off the
progenitor cells from mixed glial cell cultures as previously described
(Wang et al., 2004; Zhang et al., 2006). Briefly, mixed primary glial
cultures were prepared from 2 to 3 day-old Sprague–Dawley rats by
dissociation of the brains after they were dissected from the pups.
Cultures were maintained in Dulbecco's modified Eagle's medium
(DMEM) containing 20% heat-inactivated fetal bovine serum and 1%
penicillin/streptomycin in poly-lysine coated 75 cm2 flasks incubated
in 95% air/5% CO2, at 37 °C. The media were changed 3 times per week
until the cells were confluent (7–10 days). The flasks were then
shaken for 1 h on an orbital shaker (200 rpm) at 37 °C to remove
microglia. They were then changed to new media and shaken
overnight. The OL progenitor cells were detached from the astrocyte
layer and were resuspended and seeded onto poly-ornithine coated
plates [96-well (2×105 cells/plate), 24-well (4×105 cells/plate)] in a
basal chemically-defined medium (BDM) [DMEM with 1 mg/ml
bovine serum albumin (BSA), 50 μg/ml apo-transferrin, 5 μg/ml
insulin, 30 nM sodium selenite, 10 nM biotin, 10 nM hydrocortisone]
plus 10 ng/ml of both PDGF and bFGF. The cells were maintained in
BDM and the medium was half-changed 3 times per week. For
culturing mature OLs, OLs at day 7 were changed to BDM plus 3,3′,5-
triodo-L-thyronine (T3) (15 nM) and CNTF (10 ng/ml) and were half-
changed 3 times per week for 2 weeks. At this stage, more than 95% of
the cells were mature OLs (Baud et al., 2004; Wang et al., 2004) and
were used for the experiments. The contamination of astrocytes and
microglia was each around 2% as shown in Fig. 1.
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Fig. 7. Go6976 and rottlerin attenuated SIN-1 and zinc induced ERK1/2 phosphorylation and ROS generation in OLs. A, OLs were treated with SIN-1 or ZnCl2 (Zn) in the presence of
Go6976 or rottlerin for 2 h, and then lysed for western blot. Rottlerin has a better inhibitory effect than Go6976 on ERK1/2 phosphorylation induced by SIN-1 or ZnCl2. A
representative experiment of six that were performed is shown. B–C, Mature OLs were exposed to SIN-1 in the presence of Go6976 (B) or rottlerin (C) for 2 h, and then exposed to
DCF for 30 min. ROS generation was significantly attenuated by Go6976 and rottlerin. *, pb0.05 and **, pb0.01 were obtained when the Go6976 (1 μM and 3 μM) and the rottlerin
(1 and 3 μM) treated groups were compared with the SIN-1 alone groups. A representative experiment of six that were performed is shown. D–E, Mature OLs were exposed to ZnCl2
in the presence of Go6976 (D) or rottlerin (E) for 2 h, and then exposed to DCF for 30 min. ROS generation was significantly attenuated by Go6976 and rottlerin. **, pb0.01 and
***, pb0.001 were obtained when the Go6976 (0.1, 1 and 3 μM) and the rottlerin (0.1, 1 and 3 μM) treated groups were compared with the zinc alone groups. A representative
experiment of six that were performed is shown.
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PKC activity assay
The activity of PKC in mature OLs following oxidative stress was
measured using PKC activity assay kit from Assay Designs, Inc (Ann
Arbor, MI). In brief, OLs in 24-well plates were treated with SIN-1
(0.5 mM) or ZnCl2 (100 μM) in the absence and presence of
bisindolylmaleimide 1 (Bis-1, 10 μM) for 30 min and then lysed
with protein lysis buffer.Whole cell lysates were adjusted to the equal
protein concentration with lysis buffer and the same volume of each
sample was added to the ELISA plate, which is precoated with
crebtide, a substrate that can be readily phosphorylated by PKC. ATP
was added to each well to initiate reaction at 30 °C for 90 min. After
emptying the contents of each well, phosphospecific substrate
antibody was added and incubated for 1 h. The phosphorylated
crebtide was quantified following manufacturer's instructions.
Toxicity assay
The survival of cells after various treatments in 96-well plates was
evaluated by visual inspection using phase contrast microscopy and
quantified by Alamar Blue (Trek Diagnostic Systems, Inc., Westlake,
OH), a viability assay that was previously described and validated by
cell counting using trypan blue exclusion (Back et al., 1999). In all
experiments, the culture plates were first washed twice with Hank's
balanced salt solution (HBSS) containing 0.1% BSA and then placed in
Earle's balanced salt solution (EBSS, which is composed of 116 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 26 mM NaHCO3,
1 mM NaH2PO4 and 5.5 mM D-glucose). OLs were treated with SIN-1
or ZnCl2 for 2 h, washed twice with HBSS containing 0.1% BSA, and
then placed in BDMwith T3 and CNTF. Inhibitors of PKCs were applied
15 min before and during cell exposure to SIN-1 or ZnCl2. After cells
were incubated for 20–24 h, the culture medium was replaced with
EBSS plus a 1:100 dilution of Alamar Blue. After 2 h exposure, the
fluorescence of the Alamar Blue solution in eachwell in the plates was
read at room temperature using the Spectra MAX Gemini XS
microplate reader with excitation wavelength at 530 nm and
emission wavelength at 590 nm. The data from Alamar Blue assays
matched the results from visual inspection.
Western blot analyses
At various times after SIN-1 or zinc treatment, OLs were placed on
ice. Following medium aspiration, cells were washed once with ice-
cold phosphate-buffered saline, and lysed with lysis buffer containing
20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton X-100, 1 mM glycerolphosphate, 1 mM Na3VO4, and 1 mM
phenylmethylsulfonyl fluoride. An aliquot of cell lysate was removed
for later protein determination. Cell lysate was mixed with Laemmli
buffer, boiled for 5 min, and stored at −20 °C. Equal amounts of
protein were separated by 4–12% SDS–PAGE and electrotransferred to
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Fig. 8. Downregulation of PKCθ attenuated OL toxicity induced by zinc. A, OLs were treated with ZnCl2 in the presence of Bis-1, Go6976 (Go) or rottlerin (Ro) for 2 h, and then lysed
for western blot. ZnCl2 caused a significant increase of PKCθ phosphorylation, which was completely blocked by rottlerin, but not by Go6976. Bis-1 also slightly attenuated the
phosphorylation of PKCθ. There was no phosphorylation of PKCδ following zinc treatment. A representative experiment of three that were performed is shown. B, OLs were infected
with Lentiviral PKCθ shRNA particles for 4 days and then lysed for detection of the expression of PKCθ. Transfection with PKCθ shRNA caused a dramatic reduction of the expression of
PKCθ, when compared to the GFP shRNA transfected cells. Prolonged treatment with PMA also completely blocked the expression of PKCθ. A representative experiment of three that
were performed is shown. C–D, OLs were infectedwith Lentiviral PKCθ shRNA particles for 4 days and then treated with ZnCl2 (C) or SIN-1 (D) for 2 h. The toxicity was assessed at an
additional 24 h. Transfection with GFP shRNA had no effect on zinc or SIN-1 induced toxicity. However, transfection with PKCθ shRNA significantly attenuated cell death induced by
ZnCl2 or SIN-1. *, pb0.05 and **, pb0.01 were obtained when PKCθ shRNA transfected groups were compared with GFP shRNA transfected and the control groups following zinc or
SIN-1 treatment. A representative experiment of three that were performed is shown.
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a polyvinylidene difluoride membrane. Membranes were blocked
with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween 20
(TBST) for 1 h and then incubated overnight at 4 °C with the primary
antibodies for phosphorylated ERK1/2, total ERK1/2 (Cell Signaling,
Beverly, MA) and PKC isoform specific antibodies (BD Biosciences).
After washing with TBST, the membrane was incubated for 1 h at
room temperature with a horseradish peroxidase-conjugated anti-
rabbit or anti-mouse secondary antibody (Bio-Rad Laboratories,
Hercules, CA). The membranes were washed again as above and
visualized by enhanced chemiluminescence (ECL) according to the
manufacturer's protocol (PerkinElmer Life Sciences).
Measurement of ROS generation
Intracellular free radical generation was evaluated with DCF
(Molecular Probes, Eugene, OR) as we previously described (Wang
et al., 2004; Zhang et al., 2006). Briefly, following treatmentwith SIN-1 or
ZnCl2 with/without PKC inhibitors for 2 h, cells in 96-well plates were
loadedwithDCF (20 μM) for30 min inEBSS (95%air/5%CO2, 37 °C). After
the loading solution was removed, cells were washed and incubated in
EBSS, and the fluorescence in each well was measured and recorded in
the fluorescence plate-reader as described above (with excitation at
λ=480 nm and emission at λ=530 nm and temperature set to 37 °C).
Reverse transcriptase PCR (RT-PCR) and PCR analysis
Total RNA was isolated from mature OLs using RNeasy Mini Kit
(Qiagen, Valencia, CA) and cDNA synthesis from total RNA was
performed by ReveriAid First Strand cDNA synthesis kit (Fermentas,
Glen Burnie, MD) using 1 μg total RNA and 1 μl oligo (dT)18 following
manufacturer's instructions. 1 μl of each cDNA synthesized in the
reverse transcriptase reaction was used for PCR amplification in the
presence of 1 U Taq DNA polymerase in Tag buffer, 0.2 mM each of
dNTPs, and 1 μM of each primer. The PKC isoform specific primers
were listed in Table 1. The PCR amplification reaction used a three-
step program (30 s at 95 °C, 30 s at 60 °C, and 45 s at 72 °C) for a total
of 30 cycles. The PCR product was run on 1.5% agarose gel and
visualized under UV light.
shRNA transfection
Mature OLs were infected with PKCθ shRNA lentiviral particles (sc-
36247v, Santa Cruz Biotechnology) in the presence of polybrene
(2 μg/ml) for 24 h. Polybrene was used to enhance the binding of
lentiviral particles to cell membranes. After replacing the lentiviral
particle containing medium with the normal culture medium (BDM
plus T3 and CNTF), cells were incubated for another 3 days and then
treated with ZnCl2 (150 μM) or SIN-1 (1 mM) for 2 h. The toxicity was
assessed at 20–24 h later using Alamar Blue assay. The lentiviral
particles of copGFP (sc-108084, Santa Cruz Biotechnology) were used
as a negative control. The transfection efficiency was around 50%
when the GFP fluorescence was examined.
Statistics
Statistical significance was assessed using ANOVA with the Tukey-
Kramer post-hoc multiple comparison test. Statistical analysis was
performed using the Instat program from GraphPad Software (San
Diego, CA). Representative experiments are shown unless noted
otherwise. Experiments were performed with triplicate samples, and
the data are expressed as mean±SD. All experiments were repeated
at least 3 times.
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